MedPath
NMPA Approval

Adalimumab Solution for Injection

国药准字S20217001

March 11, 2021

国药准字S20190038

Drug Information

阿达木单抗注射液

格乐立/QLETLI

注射剂

20mg/0.4ml

生物制品

March 11, 2021

Company Information

Applicant Company

广州高新技术产业开发区科学城开源大道11号A6栋第五层

Manufacturing Company

广州市黄埔区永和经济开发区摇田河大街155号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

阿达木单抗注射液 - NMPA 批准文号 | MedPath